Blog - Page 15 of 5383 - QualityStocks

MondayJun 09, 2025 9:00 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology

Nutriband (NASDAQ: NTRB) has been granted U.S. patent No. 12,318,492 for its "Abuse and Misuse Deterrent Transdermal Systems," further strengthening domestic protection for its Aversa(TM) technology. The patent, issued June 3, 2025, enhances the company’s intellectual property portfolio for abuse-deterrent transdermal products designed to curb misuse, diversion, and accidental exposure. Aversa(TM) is currently in development as part of Nutriband’s lead product, Aversa Fentanyl, which aims to be the first abuse-deterrent fentanyl patch on the market, with peak U.S. sales potential projected between $80 million and $200 million. To view the full article, visit https://ibn.fm/BGFEy About Nutriband Inc. Nutriband is primarily…

FridayJun 06, 2025 3:47 pm

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Leads with Vision and Cutting-Edge Gear Amid Golf’s Resurgence

Newton Golf Company (NASDAQ: NWTG) is riding the wave of golf’s renewed popularity, driven by increasing diversity, inclusivity, and innovation within the sport. With more than 47 million Americans engaging in golf activities in 2024, the sport has evolved into a dynamic, accessible pastime. Newton Golf is capitalizing on this momentum by developing performance-enhancing products, including those in its Newton Motion Shaft and Gravity Putter lines, showcased at the 2025 PGA Show. The company’s strategic focus combines cutting-edge technology and community engagement, with products designed to optimize swing dynamics, improve putting accuracy and enhance performance and enjoyment for golfers of all…

FridayJun 06, 2025 3:16 pm

QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioning at the Center of Critical Materials, Innovation

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is strategically positioning itself for growth amid strong palladium market dynamics, driven by constrained supply and continued industrial demand. With palladium essential in automotive, electronics, and emerging clean energy applications, the company is advancing the Waterberg Project in South Africa—one of the largest undeveloped primary palladium and platinum projects globally. In partnership with Anglo American Platinum Limited, PLG is also investing in future-focused innovation through Lion Battery Technologies, which explores the use of platinum and palladium in next-generation lithium battery technologies. Among the few companies combining traditional mining development with tech-driven diversification, Platinum…

FridayJun 06, 2025 1:55 pm

QualityStocksNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. INBS was featured in a recent article that reads, “By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings… The company’s vision is to redefine drug screening by removing the pain points of traditional testing methods, including biohazardous waste, privacy concerns, and long result turnaround times. With results in under 10 minutes and no need for gender-specific collectors or laboratory facilities, the system empowers…

FridayJun 06, 2025 12:45 pm

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Stands Out in Booming Gold Market, Offers Strategic Investment Avenue

The gold market's current dynamics underscore the metal's enduring appeal Lahontan Gold boasts a portfolio of four gold and silver projects located in Nevada's prolific Walker Lane LGCXF’s management team comprises seasoned professionals with extensive experience in mineral exploration, project development and corporate finance LGCXF recently named as “one of the best gold developers in Nevada” In an era marked by economic volatility and geopolitical tensions, gold has reasserted itself as a premier safe-haven asset. Gold prices have soared to unprecedented levels, surpassing $3,400 per ounce, driven by factors such as trade disputes, inflationary pressures and global uncertainty (https://ibn.fm/1Z7sV). This bullish…

FridayJun 06, 2025 12:00 pm

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances

The company’s non-invasive fingerprint drug screening system uses fingerprint sweat to screen for drugs such as cannabis, cocaine, methamphetamine, and opiates. Results are available in under ten minutes, supporting faster, on-site decision-making in treatment and justice settings. INBS is pursuing FDA approval and further entry into the U.S. market, where it currently operates in a Forensic Use Only capacity. The company has over 450 active accounts in 24 countries, targeting sectors such as healthcare, justice, and workplace safety. INBS partnered with SMARTOX, a U.S. distributor, to connect with stakeholders in criminal justice and addiction recovery. Intelligent Bio Solutions (NASDAQ: INBS),…

FridayJun 06, 2025 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Tests Potential for Streamlining Tailings Process, Offering Important Cost and Environment Benefits

ESGold is a gold and silver company preparing for production later this year at a tailings reclamation site in Quebec abandoned by the previous operator The gold and silver resource developer expects to concentrate on reprocessing the tailings for the near-term to extract mica and any remaining gold and silver, anticipating that the resulting mica concentrate will be useful in a wide variety of building and roadwork materials ESGold plans to build revenue through the reuse project, which can then help fund planned exploration at its Quebec property covering 13,116 hectares (about 32,410 acres) The company is currently conducting testing…

FridayJun 06, 2025 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Offers Hope on the Horizon with HyBryte(TM) Treatment Targeting CTCL

Soligenix’s HyBryte(TM) is a photodynamic therapy using synthetically manufactured hypericin, one of the most photoactive compounds available. The therapeutic potential of HyBryte(TM) has been demonstrated through multiple clinical trials, including a Phase 3 trial in early-stage CTCL patients. HyBryte(TM) has been granted Orphan Drug Designation by the U.S. Food and Drug Administration and the European Medicines Agency. Cutaneous T-cell lymphoma (“CTCL”) is a rare and debilitating form of non-Hodgkin’s lymphoma that primarily affects the skin, posing both physical and emotional challenges for those diagnosed. With limited treatment options available and no definitive cure, the need for innovative, safe and effective…

FridayJun 06, 2025 9:35 am

QualityStocksNewsBreaks – Authentic Holdings (OTC: AHRO) Subsidiary Maybacks Signs Streaming Deal With Plex

Authentic Holdings (OTC: AHRO) announced that its wholly owned subsidiary, Maybacks Global Entertainment, LLC, has entered into a licensing and distribution agreement with Plex GmbH to bring its iDreamCTV network brands—Toro TV, Comfy TV, Winnie’s World, and iCowboy—to a global streaming audience. The partnership leverages Plex’s AVOD and FAST channel infrastructure to monetize and distribute Maybacks’ content across its 25 million-user platform. Following its acquisition of Goliath Motion Picture Promotions, Maybacks is pivoting from traditional film sales to building proprietary media brands with scalable digital reach. To view the full press release, visit https://ibn.fm/hnCSv About Authentic Holdings Authentic Holdings combines…

ThursdayJun 05, 2025 1:38 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Unveils Promising Data on CLD-401 at ASCO 2025

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to deliver genetic payloads. The company unveiled promising new data on its lead RedTail platform candidate, CLD-401, at the American Society of Clinical Oncology (“ASCO”) Annual Meeting. The announcement reads, “Calidi has previously demonstrated its pioneering efforts in developing an enveloped form of its proprietary oncolytic virus that is significantly more resistant to immune clearance than non-enveloped forms, allowing for systemic delivery and efficacy in syngeneic tumor-bearing pre-clinical models. Calidi has further advanced this technology with CLD-401, its first…

Site Search

Company Search